top of page
Dr. Yair Lotan on the BackTable Urology Podcast

Dr. Yair Lotan

Urologic Oncologist

1 Podcast • 1 Course on BackTable

Dr. Yair Lotan is a professor of urology and chief of urologic oncology with UT Southwestern in Dallas, Texas.

Learn from the experiences and expertise of Dr. Yair Lotan and other leading voices in your specialty on the BackTable app.

Adjuvant Therapy for High Risk Bladder Cancer
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

Urology

Episode # 103  •  21 Jun 2023

Adjuvant Therapy for High Risk Bladder Cancer

In this episode of BackTable Urology, Dr. Aditya Bagrodia invites Dr. Yair Lotan, professor of urologic oncology at UT Southwestern, and oncologist Dr. Suzanne Cole to discuss types of adjuvant treatment for high risk bladder cancer, including chemotherapy, radiation therapy, and immunotherapy.

This podcast is supported by:

Veracyte

More from Dr. Yair Lotan

Loading recent podcasts…

Bladder Cancer Topics

Urology Course

2.5 hours, 43 lessons

About

Yair Lotan, M.D., is a Professor of Urology, Chief of Urologic Oncology, and holder of the Jane and John Justin Distinguished Chair in Urology, in Honor of Claus G. Roehrborn, M.D. at UT Southwestern Medical Center. He is also the Medical Director of the Urology Clinic at UT Southwestern and Parkland Health and Hospital System.
He was class valedictorian in high school and graduated with high honors from the University of Texas at Austin and Baylor College of Medicine in Houston. He trained in general surgery and urology at UT Southwestern and joined the faculty in 2003.

A board-certified urologist, Dr. Lotan treats patients with bladder, prostate, kidney, ureteral, and testicular cancer. He also handles general urologic conditions, such as kidney stones and vasectomies.

He is known nationally for his research on urine markers and molecular markers, which will help determine which patients are at higher risk for recurrent cancer. He is also involved in health economics research, which evaluates the cost-effectiveness of surgery and cancer prevention. Dr. Lotan is the co-chair of the Harold C. Simmons Comprehensive Cancer Center disease oriented team for urologic cancers. He is also a member of UT Southwestern’s Clinical Research Planning Group and the Tissue Bank Steering Committee and Cancer Committee.
He is a frequent guest speaker at medical conferences around the world and belongs to numerous professional organizations, including the American Urological Association, the Society of Urologic Oncology, and the Bladder Cancer Advocacy Network.

He has published hundreds of research articles and several book chapters on urologic care and procedures, and he serves as editorial reviewer for medical periodicals such as the Journal of Urology, European Urology, Cancer, Urologic Oncology, and the British Journal of Urology International.

Learn more by visiting Dr. Yair Lotan's practice:

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page